ENRIGHT PATRICK G (CIK 1253886) reported 21 SEC Form 4 insider transactions across 5 companies over the past 18 months (most recent 2026-02-06). Recent activity: Sell RPID (49,000 shares), Buy MANE (1.2M shares), Buy MANE (1.2M shares), Buy MANE (1.2M shares), Buy MANE (192,647 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-06 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Sell | 49,000 | $190,120 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 1.2M | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 1.2M | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 1.2M | $0 |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 192,647 | $3.3M |
| 2026-02-05 | Veradermics, Inc (MANE) | Director | Buy | 882,353 | $15.0M |
| 2026-02-03 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Buy | 629,032 | $31,452 |
| 2026-02-03 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Sell | 7,739 | $31,420 |
| 2026-02-03 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Sell | 46,000 | $208,840 |
| 2026-02-03 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Sell | 27,500 | $116,875 |
| 2026-02-03 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Insider | Sell | 27,500 | $116,600 |
| 2026-01-08 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 5,000 | $0 |
| 2025-12-15 | Vera Therapeutics, Inc. (VERA) | Director | Buy | 5,882 | $249,985 |
| 2025-10-14 | Zenas BioPharma, Inc. (ZBIO) | Director | Buy | 105,265 | $2.0M |
| 2025-10-14 | Zenas BioPharma, Inc. (ZBIO) | Director | Buy | 11,990 | $249,992 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
| 2025-06-25 | Vera Therapeutics, Inc. (VERA) | Director | Buy | 69,798 | $1.5M |
| 2025-06-25 | Vera Therapeutics, Inc. (VERA) | Director | Buy | 139,595 | $2.9M |
| 2025-06-25 | Vera Therapeutics, Inc. (VERA) | Director | Buy | 13,536 | $302,530 |
| 2025-06-25 | Vera Therapeutics, Inc. (VERA) | Director | Buy | 27,071 | $605,037 |
Source: SEC Form 4 filings · as of 2026-02-06